Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance
出版年份 2019 全文链接
标题
Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 17, Pages 4242
出版商
MDPI AG
发表日期
2019-08-30
DOI
10.3390/ijms20174242
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase Ib study of WNT inhibitor ipafricept (IPA) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (mPC).
- (2019) Efrat Dotan et al. JOURNAL OF CLINICAL ONCOLOGY
- Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases
- (2019) Himavanth Gatla et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors
- (2019) Andrea Wang-Gillam et al. EUROPEAN JOURNAL OF CANCER
- A Ca2+-ATPase Regulates E-Cadherin Biogenesis and Epithelial-Mesenchymal Transition in Breast Cancer Cells
- (2019) Donna K Dang et al. MOLECULAR CANCER RESEARCH
- Silencing LGR6 Attenuates Stemness and Chemoresistance via Inhibiting Wnt/β-Catenin Signaling in Ovarian Cancer
- (2019) Xiaohong Ruan et al. Molecular Therapy-Oncolytics
- MicroRNA-449a functions as a tumor suppressor in pancreatic cancer by the epigenetic regulation of ATDC expression
- (2018) Feng Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Antagonistic role of Klotho-derived peptides dynamics in the pancreatic cancer treatment through obstructing WNT-1 and Frizzled binding
- (2018) Muhammad Fakhar et al. BIOPHYSICAL CHEMISTRY
- A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients
- (2018) Anne-Laure Giraudet et al. BMC CANCER
- Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study
- (2018) Anas M. Saad et al. BMC CANCER
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
- (2018) Nithya Krishnamurthy et al. CANCER TREATMENT REVIEWS
- CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway
- (2018) Yue-Ming He et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Targeting glypican-4 overcomes 5-FU resistance and attenuates stem cell-like properties via suppression of Wnt/β-catenin pathway in pancreatic cancer cells
- (2018) Junyu Cao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Therapeutic developments in pancreatic cancer: current and future perspectives
- (2018) John P. Neoptolemos et al. Nature Reviews Gastroenterology & Hepatology
- Identification of potential target genes in pancreatic ductal adenocarcinoma by bioinformatics analysis
- (2018) Yuchen Tang et al. Oncology Letters
- Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer
- (2018) Philipp Manegold et al. Cancers
- Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia
- (2018) Michael M. Song et al. ANTI-CANCER DRUGS
- Abstract 4812: Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid malignancies via reactive oxygen species
- (2018) Monish Ram Makena et al. CANCER RESEARCH
- Cytotoxic activity of difluoromethylornithine compared with fenretinide in neuroblastoma cell lines
- (2018) Monish R. Makena et al. PEDIATRIC BLOOD & CANCER
- High expression of WNT7A predicts poor prognosis and promote tumor metastasis in pancreatic ductal adenocarcinoma
- (2018) Dong-jin Wu et al. Scientific Reports
- Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance
- (2018) Monish Ram Makena et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Long non-coding RNA LINC01133 silencing exerts antioncogenic effect in pancreatic cancer through the methylation of DKK1 promoter and the activation of Wnt signaling pathway
- (2018) Yuan-Chi Weng et al. CANCER BIOLOGY & THERAPY
- Advancement of NF-κB Signaling Pathway: A Novel Target in Pancreatic Cancer
- (2018) Kartick Pramanik et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer
- (2018) Yunpeng Sun et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Temporal dynamics of Wnt-dependent transcriptome reveal an oncogenic Wnt/MYC/ribosome axis
- (2018) Babita Madan et al. JOURNAL OF CLINICAL INVESTIGATION
- Restoration of miRNA‑148a in pancreatic cancer reduces invasion and metastasis by inhibiting the Wnt/β‑catenin signaling pathway via downregulating maternally expressed gene‑3
- (2018) Yunpeng Sun et al. Experimental and Therapeutic Medicine
- Histone Deacetylase (HDAC) Inhibition Induces IκB Kinase (IKK)-dependent Interleukin-8/CXCL8 Expression in Ovarian Cancer Cells
- (2017) Himavanth R. Gatla et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells
- (2017) Jia-Qiang Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Rnf43
- (2017) Stefano Serra et al. JOURNAL OF CLINICAL PATHOLOGY
- Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer
- (2017) Qi Zhang et al. Molecular Cancer
- Reactive Oxygen Species–Mediated Synergism of Fenretinide and Romidepsin in Preclinical Models of T-cell Lymphoid Malignancies
- (2017) Monish R. Makena et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA-195 inhibits the proliferation and invasion of pancreatic cancer cells by targeting the fatty acid synthase/Wnt signaling pathway
- (2017) Zhichao Xu et al. TUMOR BIOLOGY
- Expression of Rab5a correlates with tumor progression in pancreatic carcinoma
- (2017) Yuandong Li et al. VIRCHOWS ARCHIV
- Sodium fluoride PET imaging as a quantitative pharmacodynamic biomarker for bone homeostasis during anti-DKK1 therapy for multiple myeloma
- (2017) Y Wang et al. Blood Cancer Journal
- Dishevelled1-3 contribute to multidrug resistance in colorectal cancer via activating Wnt/β-catenin signaling
- (2017) Kun Zhang et al. Oncotarget
- Epigenetic regulation of interleukin-8 expression by class I HDAC and CBP in ovarian cancer cells
- (2017) Himavanth R. Gatla et al. Oncotarget
- Curcumin Suppresses the Colon Cancer Proliferation by Inhibiting Wnt/β-Catenin Pathways via miR-130a
- (2017) Huiqiang Dou et al. Frontiers in Pharmacology
- WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death
- (2017) Marcus M. Fischer et al. Science Advances
- Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model
- (2017) Giacomo Canesin et al. PLoS One
- Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC)
- (2016) W. Messersmith et al. ANNALS OF ONCOLOGY
- Phase 1b study of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC)
- (2016) C. Weekes et al. ANNALS OF ONCOLOGY
- Over-expression of microRNA-940 promotes cell proliferation by targeting GSK3β and sFRP1 in human pancreatic carcinoma
- (2016) Hong-wei Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma
- (2016) Kapo Saukkonen et al. BMC CANCER
- Wnt/β-catenin pathway in tissue injury: roles in pathology and therapeutic opportunities for regeneration
- (2016) Dikshya Bastakoty et al. FASEB JOURNAL
- MM-398 (nanoliposomal irinotecan): emergence of a novel therapy for the treatment of advanced pancreatic cancer
- (2016) Julia Carnevale et al. Future Oncology
- Vitamin D3 Inhibits Wnt/β-Catenin and mTOR Signaling Pathways in Human Uterine Fibroid Cells
- (2016) Ayman Al-Hendy et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Wnt signaling in cancer
- (2016) T Zhan et al. ONCOGENE
- Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer
- (2016) Jian-xin Jiang et al. TUMOR BIOLOGY
- Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer
- (2016) Li Yu et al. TUMOR BIOLOGY
- Epidemiology of pancreatic cancer
- (2016) Milena Ilic et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Pancreatic cancer
- (2016) Jorg Kleeff et al. Nature Reviews Disease Primers
- DKK1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell lines
- (2015) Hogir Salim et al. BMC CANCER
- Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway
- (2015) Wei Xu et al. CANCER LETTERS
- Silencing of LRRFIP1 reverses the epithelial–mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway
- (2015) Daisuke Douchi et al. CANCER LETTERS
- Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates -Catenin Signaling and Tumorigenesis in Multiple Cancer Types
- (2015) C. Chartier et al. CANCER RESEARCH
- Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/ -Catenin Signaling
- (2015) M. Quan et al. CANCER RESEARCH
- RSPO2 Enhances Canonical Wnt Signaling to Confer Stemness-Associated Traits to Susceptible Pancreatic Cancer Cells
- (2015) M. Ilmer et al. CANCER RESEARCH
- Activity of MM-398, Nanoliposomal Irinotecan (nal-IRI), in Ewing's Family Tumor Xenografts Is Associated with High Exposure of Tumor to Drug and High SLFN11 Expression
- (2015) M. H. Kang et al. CLINICAL CANCER RESEARCH
- Control of Apoptosis in Treatment and Biology of Pancreatic Cancer
- (2015) Shrey Modi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Calcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer
- (2015) M. D. Arensman et al. MOLECULAR CANCER RESEARCH
- Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
- (2015) E. Martinez-Balibrea et al. MOLECULAR CANCER THERAPEUTICS
- Upregulation of the expression of Wnt5a promotes the proliferation of pancreatic cancer cells in vitro and in a nude mouse model
- (2015) HAIJI BO et al. Molecular Medicine Reports
- Wnt addiction of genetically defined cancers reversed by PORCN inhibition
- (2015) B Madan et al. ONCOGENE
- Targeting the WNT Signaling Pathway in Cancer Therapeutics
- (2015) D. Tai et al. ONCOLOGIST
- Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28
- (2015) Phuong N. Le et al. PHARMACOLOGY & THERAPEUTICS
- miR-33a suppresses the nuclear translocation of β-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells
- (2015) Chen Liang et al. TUMOR BIOLOGY
- The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2
- (2015) Nicolas Skrypek et al. Oncotarget
- MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway
- (2015) Wei Zhou et al. Oncotarget
- The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine
- (2015) Deok-Beom Jung et al. Oncotarget
- Canonical Wnt Pathway Inhibitor ICG-001 Induces Cytotoxicity of Multiple Myeloma Cells in Wnt-Independent Manner
- (2015) Eileen R. Grigson et al. PLoS One
- WNT5A-NFAT Signaling Mediates Resistance to Apoptosis in Pancreatic Cancer
- (2015) Heidi Griesmann et al. NEOPLASIA
- Eflornithine (DFMO) Prevents Progression of Pancreatic Cancer by Modulating Ornithine Decarboxylase Signaling
- (2014) A. Mohammed et al. Cancer Prevention Research
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Safely targeting cancer stem cells via selective catenin coactivator antagonism
- (2014) Heinz-Josef Lenz et al. CANCER SCIENCE
- 5-Azacytidine suppresses the proliferation of pancreatic cancer cells by inhibiting the Wnt/β-catenin signaling pathway
- (2014) H. Zhang et al. GENETICS AND MOLECULAR RESEARCH
- WNT5A modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells
- (2014) Wei Wei et al. Hepatobiliary & Pancreatic Diseases International
- The CREB-Binding Protein Inhibitor ICG-001 Suppresses Pancreatic Cancer Growth
- (2014) M. D. Arensman et al. MOLECULAR CANCER THERAPEUTICS
- Can we safely target the WNT pathway?
- (2014) Michael Kahn NATURE REVIEWS DRUG DISCOVERY
- Reversion of trichostatin A resistance via inhibition of the Wnt signaling pathway in human pancreatic cancer cells
- (2014) BENQUAN WANG et al. ONCOLOGY REPORTS
- Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis
- (2014) Hanno Niess et al. Targeted Oncology
- MUC1 regulates cyclin D1 gene expression through p120 catenin and β-catenin
- (2014) X Liu et al. Oncogenesis
- MUC4-induced nuclear translocation of β-catenin: A novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer
- (2013) Xiaofei Zhi et al. CANCER LETTERS
- PanIN-Specific Regulation of Wnt Signaling by HIF2 during Early Pancreatic Tumorigenesis
- (2013) A. Criscimanna et al. CANCER RESEARCH
- -Catenin Signaling Is a Critical Event in ErbB2-Mediated Mammary Tumor Progression
- (2013) B. Schade et al. CANCER RESEARCH
- MicroRNA-29a induces resistance to gemcitabine through the Wnt/β-catenin signaling pathway in pancreatic cancer cells
- (2013) HIROAKI NAGANO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma
- (2013) X. Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multiple functions of the noncanonical Wnt pathway
- (2013) Eva Gómez-Orte et al. TRENDS IN GENETICS
- Wnt/β-Catenin Signaling and Disease
- (2012) Hans Clevers et al. CELL
- Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition
- (2012) KARL QUINT et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Precise Regulation of Porcupine Activity Is Required for Physiological Wnt Signaling
- (2012) Kyle D. Proffitt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Omega-3-Polyunsaturated Fatty Acids Suppress Pancreatic Cancer Cell Growth in vitro and in vivo via Downregulation of Wnt/Beta-Catenin Signaling
- (2012) Kyoung-Sub Song et al. PANCREATOLOGY
- Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
- (2012) A. Gurney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GATA6 Activates Wnt Signaling in Pancreatic Cancer by Negatively Regulating the Wnt Antagonist Dickkopf-1
- (2011) Yi Zhong et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now